FDA takes key action by approving second COVID-19 vaccine
WASHINGTON, D.C. – On Monday, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older. Key points: Spikevax meets the FDA’s rigorous standards […]
FDA takes key action by approving second COVID-19 vaccine Read More »